Outcomes for peripheral vascular intervention and lower extremity bypass in kidney transplant recipients are superior to outcomes of patients remaining on dialysis

BackgroundImproved survival is reported for patients with end-stage renal disease who are kidney transplant recipients (KTRs) compared with dialysis-dependent patients (DDPs). Whether amputation-free survival (AFS) and freedom from major adverse limb events (MALEs) after peripheral vascular intervention (PVI) or lower extremity bypass (LEB) are superior after renal transplantation remains incompletely defined.MethodsA retrospective cohort study was undertaken of KTRs and DDPs undergoing infrainguinal PVI or LEB for symptoms of limb-threatening ischemia recorded in the Vascular Quality Initiative from 2003 to 2017. Primary outcomes were AFS and freedom from MALEs along with their components of assisted primary patency, limb salvage, and patient survival. The χ² tests and independent samples t-tests were used to compare demographic variables. Kaplan-Meier survival analyses were used to estimate outcomes, and Cox regression analyses were used to confirm independent predictors of outcome.ResultsThere were 2707 PVI (351 KTRs and 2356 DDPs) and 1444 LEB (198 KTRs and 1246 DDPs) procedures performed for limb-threatening ischemia. Chronic obstructive pulmonary disease, congestive heart failure, female patients, and African Americans were more common among the DDP group, as were lower preoperative hemoglobin values and older age. After PVI, KTRs had better AFS than DDPs (42% vs 66% at 1 year, 15% vs 26% at 2 years; hazard ratio [HR], 1.91; 95% confidence interval [CI], 1.38-2.64; P < .001) and fewer MALEs (53% vs 64% at 1 year, 35% vs 49% at 18 months; HR, 1.71; 95% CI, 1.25-2.34; P = .001). PVI outcomes, AFS, and freedom from MALEs were driven primarily by differences in limb salvage and patient survival but not assisted primary patency. After LEB, KTRs also displayed improved AFS compared with DDPs (44% vs 65% at 1 year, 10% vs 36% at 3 years; HR, 2.32; 95% CI, 1.41-3.81; P = .001), driven by patient survival but not limb salvage, whereas differences in freedom from MALEs did not attain statistical significance (67% vs 58%; P = .08).ConclusionsFor patients with end-stage renal disease, subsequent kidney transplantation was associated with better AFS and freedom from MALEs after PVI but only improved AFS after LEB. Open or endovascular revascularization can be advocated in patients with limb-threatening ischemia who have received kidney transplantation to a greater degree than in those who remain dialysis dependent.     

Risk score for nonhome discharge after lower extremity bypass

ObjectivePatients undergoing lower extremity bypass (LEB) for peripheral artery disease require intensive health care resource utilization including rehabilitation and skilled nursing facilities. However, few studies have evaluated factors that lead to nonhome discharge (NHD) in this population of patients. This study sought to predict NHD by preoperative risk factors in patients undergoing LEB for peripheral artery disease using a novel risk score.MethodsThe Vascular Study Group of New England database was queried for elective LEB for peripheral artery disease including claudication and critical limb ischemia from 2003 to 2017. Patients were excluded if the procedure was not elective, if they were not admitted from home, if they were bedridden, or if they died during the index admission. Only preoperative factors were considered in the analysis. The primary end point was NHD including rehabilitation and skilled nursing facilities. Data were split two-thirds for model derivation and one-third for validation. In the derivation cohort, bivariate analysis assessed the association of preoperative factors with NHD. A parsimonious manual stepwise binary logistic regression for NHD aimed at maximizing the C statistic while maintaining model simplicity was performed. A risk score was developed using the β coefficients and applied to the validation data set. The risk score performance was assessed using a C statistic and Hosmer-Lemeshow test for model fit.ResultsThere were 10,145 cases included with an overall NHD rate of 26.4% (n = 2676). Mean age was 66 years (range, 41-90 years). NHD patients were older (72 years vs 64 years; P < .01) and more frequently male (57.2% vs 42.8%; P < .01) and nonwhite (16.1% vs 9.9%; P < .01); they more frequently had tissue loss (54.2% vs 23.0%; P < .01), anemia (16.0% vs 5.3%; P < .01), severe cardiac comorbidity (21.8% vs 10.5%; P < .01), and insulin-dependent diabetes (33.3% vs 18.2%; P < .01). On multivariable analysis, factors associated with NHD included age, sex, nonwhite race, tissue loss, cardiac comorbidity, partial ambulatory deficit, and insulin-dependent diabetes. The C statistic was 0.78 in the derivation group and 0.79 in the validation group, with Hosmer-Lemeshow P > .999. The risk score ranged from 0 to 18, with a mean score of 4 (standard deviation ±3.5). The risk score was divided into low risk (0-4 points; n = 5272 [52%]; NHD = 10.1%]), moderate risk (5-9 points; n = 3663 [36.7%]; NHD = 36.7%), and high risk (≥10 points; n = 1210 [11.9%]; NHD = 66.1%).ConclusionsThis novel risk score was highly predictive for NHD after LEB for peripheral artery disease using only preoperative comorbidities. High-risk patients account for 12% of LEB but nearly a third of all patients requiring NHD. This risk score can be used preoperatively to determine high-risk patients for NHD, which may help improve preoperative counseling and hospital efficiency by allocating resources appropriately.     

The impact of chronic kidney disease on lower extremity bypass outcomes in patients with critical limb ischemia

Objective

Patient selection for open lower extremity revascularization in patients with chronic kidney disease (CKD) remains a clinical challenge. This study investigates the impact of CKD on early graft failure, postoperative complications, and mortality in patients undergoing lower extremity bypass for critical limb ischemia.

Late results of coronary bypass in patients presenting with lower extremity ischemia: the cleveland clinic study

Cardiac catheterization was performed in a prospective series of 1000 patients under consideration for elective peripheral vascular reconstruction from 1978–1982. Of these, 381 (mean age 62) presented primarily because of lower extremity ischemia. Severa, surgically correctable coronary artery disease (CAD) was documented in 79 (21 %) of the leg group, and 68 (18 %) received myocardial revascularization, with three fatal complications (4.4 %). In this subset, 39 patients have had uneventful aortoiliac, femoropopliteal or distal extremity procedures, compared to an operative mortality of 23 % for 13 others with uncorrected or inoperable CAD (p=0.015). A total of 286 patients have undergone 407 peripheral vascular operations with eight early daths (2.8 %). An additional 114 patients (30 %) died during the late follow-up interval, including 48 (13 %) with cardiac events. Both the cumulative 5-year survival (72 %) and cardiac mortality (16 %) after coronary bypass are superior to comparable figures (21 % and 56 %, respectively) among 36 other patients with severe, uncorrected or inoperable CAD (p=0.0001). Five-year survival appears to be improved by myocardical revascularization in men (p=0.0027), hypertensives (p=0.0001), nondiabetics (p=0.0002) and those over 60 years of age (p=0.0072).     

Malabsorptive gastric bypass in patients with superobesity

Weight loss in superobese patients has been problematic after conventional gastric restrictive operations including conventional Roux-en-Y gastric bypass (RYGB). The goal of the present study was to compare weight loss in patients with superobesity (body mass index ≥50 kg/m²) using a distal RYGB (D-RY) in which the Roux-en-Y anastomosis was performed 75 cm proximal to the ileocecal junction (N = 47) vs. patients who had Roux limbs of 150 cm (N = 152) and 50 to 75 cm (N = 99). All operations incorporated the same gastric restrictive parameters. Minimum follow-up was 3 years and ranged to 16 years. Weight loss and reduction in body mass index were significantly greater after D-RY vs. both RYGB-150 cm and short RYGB and in RYGB-150 cm vs. short RYGB through 5 years. Mean percentage of excess weight loss peaked at 64% after DRY, at 61% after RYGB-150 cm, and at 56% after short RYGB. Weight loss maintenance through 5 years was correlated with Roux limb length with D-RY greater than RYGB-150 cm greater than short RYGB. More than 95% of obesity-related comorbid conditions improved or resolved with weight loss. There was no difference in the early postoperative morbidity rates: 9% after D-RY; 8% after RYGB-150 cm; and 2% after short RYGB with one death (0.3 %). All D-RY patients had at least one postoperative metabolic abnormality. Anemia was significantly more common after D-RY vs. the shorter RYGB with no difference in the incidence of metabolic sequelae between RYGB-150 cm and short RYGB. No operations were reversed or modified for nutritional complications. Two D-RY patients required total parenteral nutrition for protein malnutrition. These results show that Roux limb length is correlated with weight loss in superobese patients. However, the greater incidence of metabolic sequelae after D-RY vs. RYGB-150 cm calls into question its routine use in superobese patients undergoing bariatric surgery. We conclude that some degree of malabsorption should be incorporated into bariatric operations performed in superobese patients to achieve satisfactory long-term weight loss. Presented at the Forty-Second Annual Meeting of The Society for Surgery of the Alimentary Tract, Atlanta, Georgia, May 20–23, 2001.     

Overuse of early peripheral vascular interventions for claudication

ObjectiveGuidelines from the Society for Vascular Surgery and the Choosing Wisely campaign recommend that peripheral vascular interventions (PVIs) be limited to claudication patients with lifestyle-limiting symptoms only after a failed trial of medical and exercise therapy. We sought to explore practice patterns and physician characteristics associated with early PVI after a new claudication diagnosis to evaluate adherence to these guidelines.MethodsWe used 100% Medicare fee-for-service claims to identify patients diagnosed with claudication for the first time between 2015 and 2017. Early PVI was defined as an aortoiliac or femoropopliteal PVI performed within 6 months of initial claudication diagnosis. A physician-level PVI utilization rate was calculated for physicians who diagnosed >10 claudication patients and performed at least one PVI (regardless of indication) during the study period. Hierarchical multivariable logistic regression was used to identify physician-level factors associated with early PVI.ResultsOf 194,974 patients who had a first-time diagnosis of claudication during the study period, 6286 (3.2%) underwent early PVI. Among the 5664 physicians included in the analysis, the median physician-level early PVI rate was low at 0% (range, 0%-58.3%). However, there were 320 physicians (5.6%) who had an early PVI rate ≥14% (≥2 standard deviations above the mean). After accounting for patient characteristics, a higher percentage of services delivered in ambulatory surgery center or office settings was associated with higher PVI utilization (vs 0%-22%; 23%-47%: adjusted odds ratio [aOR], 1.23; 48%-68%: aOR, 1.49; 69%-100%: aOR, 1.72; all P < .05). Other risk-adjusted physician factors independently associated with high PVI utilization included male sex (aOR, 2.04), fewer years in practice (vs ≥31 years; 11-20 years: aOR, 1.23; 21-30 years: aOR, 1.13), rural location (aOR, 1.25), and lower volume claudication practice (vs ≥30 patients diagnosed during study period; ≤17 patients: aOR, 1.30; 18-29 patients: aOR, 1.35; all P < .05).ConclusionsOutlier physicians with a high early PVI rate for patients newly diagnosed with claudication are identifiable using a claims-based practice pattern measure. Given the shared Society for Vascular Surgery and Choosing Wisely initiative goal to avoid interventions for first-line treatment of claudication, confidential data-sharing programs using national benchmarks and educational guidance may be useful to address high utilization in the management of claudication.     

Major lower extremity amputations at a Veterans Affairs hospital

BACKGROUND: This study was made to evaluate the experience at a Department of Veterans Affairs (VA) hospital with consecutive major lower extremity amputations over a period of 7 years. METHODS: The records of 229 patients (221 male and 8 female) who underwent 296 consecutive major lower extremity amputations (119 above-knee amputations [AKA] and 177 below-knee amputations [BKA]) over a period of 86 months (September 1994 to October 2001) were retrospectively analyzed. All amputations were performed by members of the vascular surgery department. RESULTS: Forty of the 229 patients (17%) eventually required a contralateral amputation, 27 patients (12%) had BKAs that eventually necessitated conversion to AKA, and 44 amputations (15%) required an initial guillotine amputation. The 30-day mortalities for BKA, AKA, and BKA to AKA operations were 12%, 17%, and 7%, respectively. Eighty-eight of the amputations (30%) developed wound complications, and required 137 revisions. Seventy-seven of the amputations (26%) had undergone prior revascularization, of which 31 (48%) had an early failed bypass. The average preoperative ankle/brachial index (ABI) was 0.57. Of the patients undergoing amputation, 97 (42%) complained of rest pain, 91 (40%) complained of claudication, and 158 (69%) had tissue loss or gangrene at the time of their operation. One hundred and forty-six patients (64%) were diabetic. Twenty-two patients (9%) were dialysis dependent and 81 patients (35%) admitted to smoking. Of the known causes of death, 21 resulted from myocardial infarction, 22 from congestive heart failure, 14 from respiratory failure, 13 from disseminated cancer, 10 from sepsis, 7 from stroke, and 6 from renal failure. Preoperative functional status determinations revealed that of 272 patients with enough information to assess functional status, 43 were totally dependent, 97 were partially independent, and 132 were independent. Of the 229 patients, 168 (73%) were ambulatory prior to their amputation, and at the completion of this review only 53 patients (23%) were ambulatory. CONCLUSIONS: Most patients undergoing major lower extremity amputations have many comorbidities; hence morbidity and mortality rates are high, with the most common causes of death being cardiac and respiratory in nature. These data suggest that major lower extremity amputations highlight a very high-risk population with only 39% survival at 7 years, as well as a costly subset secondary to prolonged hospitalization times (average 15 days, range 3 to 105), in addition to the extraordinary cost associated with diminished functional status.     

The influence of socioeconomic factors on gender disparities in lower extremity bypass

Background

Some contend that gender differences in outcomes after lower extremity bypass (LEB) for peripheral arterial disease (PAD) relate to socioeconomic factors (SEFs). Here, we evaluate these disparities with attention to clinically relevant yet understudied SEF.

Methods

A retrospective cohort study of patients aged >50 y with PAD undergoing LEB was performed using data from Pennsylvania Health care and Cost Containment Council (2003–2011). Multivariable logistic regression modeling was performed to evaluate the association between gender and outcomes with adjustment for potential confounders including SEF such as income, insurance provider, distance to hospital, and race. Generalized estimating equations were used to adjust for hospital clustering. Independent models were developed to examine death or serious morbidity (DSM) and failure-to-rescue (FTR).

Results

Of 4202 patients identified, 1510 (36%) were women. SEF differed by gender. DSM was more frequent in women (15.6% versus 12.2%; P = 0.002). There was no association between gender and FTR in univariate analysis (P = 0.49). SEFs were associated with DSM and FTR. After adjustment for potential confounders including SEF, women remained more likely to experience DSM (odds ratio = 1.28; P = 0.01). There remained no significant association between gender and FTR on independent modeling (odds ratio = 0.49; P = 0.11).

Conclusions

Women undergoing LEB in the state of Pennsylvania are at increased risk of poor outcomes, which is not completely explained by SEF. Quality of postoperative care does not appear to be different between gender as there was no difference in FTR. To improve these outcomes, efforts should be made to increase awareness of PAD and promote screening among high-risk women to ensure timely diagnosis and referral.     

下肢动脉搭桥术后移植物闭塞的外科治疗体会

目的探讨下肢动脉搭桥术后再缺血的治疗策略。方法选择2002年7月～2006年2月我院收治下肢动脉搭桥术后移植物闭塞患者21例，男17例，女4例，平均68．2岁；21例患者共行手术35例次：再次下肢动脉搭桥术16例次（45．7％），单纯人工血管取栓手术10例次（28．6％），人工血管取栓同时行股或胭动脉内膜剥脱术6例次（17．1％），3例患者行截肢术（8．6％）。结果35例次手术探查发现移植物闭塞原因以远侧流出道病变（62．9％）和远侧吻合口内膜增生（25．7％）为主。其中13例次术后再次闭塞行手术治疗，但人工血管搭桥术平均再发闭塞时间明显长于其他术式。2例患者围手术期死亡。17例患者末次行血运重建手术，术后随访6—44个月，平均17个月，未见缺血症状复发。结论下肢动脉搭桥术后移植物闭塞原因以远侧流出道病变为主，再次搭桥手术可作为首选术式，术后缺血反复发作导致截肢。     

下肢骨折病人术后35天内深静脉血栓的发生情况及危险因素分析

目的 探讨下肢骨折病人出院后35 d内深静脉血栓形成（deep vein thrombosis, DVT）的发生率及危险因素。方法 回顾性分析2014年7月至2017年7月西安交通大学医学院附属红会医院创伤骨科收治的402例住院期间未发生DVT的下肢骨折病人的临床资料。所有病人术前、术后都常规用物理方法和药物抗凝预防DVT,嘱咐病人出院后口服利伐沙班抗凝至术后35 d,记录术后35 d复查时双下肢DVT的发生情况。根据术后35 d门诊复查双下肢超声结果将病人分为DVT组和非DVT组,分析比较两组病人的性别、年龄、骨折部位、身体质量指数、合并其他骨折、合并内科疾病、术后的实验室检查（D-二聚体）、术后住院时间的差异,对上诉结果中差异有统计学意义的变量进一步采用多因素Logistic回归分析,分析病人出院后DVT的危险因素。结果 402例下肢骨折病人出院后发生DVT的有56例（13.9%）,其中2例（0.50%）发生肺栓塞,2例均合并有小腿肌间静脉血栓,1例发生在术后3周,1例在术后4周发生致死性肺栓塞。周围型52例,单纯中央型0例,混合型4例。膝关节以近的骨折病人DVT发生率为15.5%（36/232）,膝关节周围骨折病人DVT发生率为13.8%（8/58）,膝关节以远骨折病人DVT发生率10.7%（12/112）。两组间年龄、合并其他骨折、术后住院时间、冠心病、术后1 d D-二聚体、出院时D-二聚体的差异有统计学意义（P＜0.05）,多因素Logistic回归分析显示年龄＞60岁［OR=3.207,95% CI（2.007,8.553）,P=0.009］、合并其他骨折［OR=7.111,95% CI（2.297,22.011）,P＜0.001］、术后住院时间＜7 d［OR=1.448,95% CI（1.225,1.718）,P=0.020］、出院时D-二聚体偏高［OR=1.355,95% CI（0.892,12.626）,P=0.027］是出院后DVT的独立危险因素。结论 虽然出院前常规使用物理方法和药物抗凝预防DVT,出院后嘱咐病人口服利伐沙班35 d,但是出院时没有DVT的下肢骨折病人术后35 d仍有发生DVT的可能（13.9%）,严重者还会发生肺栓塞,年龄、合并其他骨折、术后住院时间较短、出院时D-二聚体是出院后DVT发生的独立危险因素。     

121例腹腔镜Roux-en-Y胃空肠吻合术后随访结果

目的探讨腹腔镜Roux-en-Y胃空肠吻合术(laparoscopicRoux-en-Ygastricbypass,LRYGBP)治疗病态肥胖的术后营养和代谢方面的变化。方法121例LRYGBP,男40例,女81例。分别测定术前1个月及术后6个月的体重指数(bodymassindex,BMI)。对比分析6个月、12个月,24个月血清铁(Fe)、钙(Ca)、锌(Zn)、硒(Se)及维生素A(VitA)、维生素D(VitD)、维生素B12(VitB12)和甲状旁腺素(parathyroidhormone,PTH)的水平变化。结果术前1个月BMI(47.00±7.15)kg/m2,术后6个月BMI(33.79±6.06)kg/m2,BMI下降(13.21±5.47)kg/m2(t=26·103,P=0·000)。术后血清Fe、Ca、Zn、Se及VitA、VitD、VitB12均在正常范围,其中术后6个月血清Zn、Se和VitA水平虽然在正常范围内,但分别有19.5%(17/87)、22.7%(20/88)和33.7%(28/83)的患者低于正常水平,但术后2年仅有6·7%(2/30)、11·5%(3/26)和17·2%(5/29)的患者低于正常水平。血清PTH术后6个月11~161pg/ml,(66±34)pg/ml、1年24~154pg/ml,(72±34)pg/ml、2年21~194pg/ml,(75±40)pg/ml(正常值9~44pg/ml)。结论LRYGBP治疗病态肥胖是有效、安全的。术后2年血清Fe、Ca及VitD、VitB12均正常;血清锌、硒及维生素A经术后6个月给予补充剂大多接近正常;血清PTH水平明显高于正常。建议患者术后长期服用复合维生素、矿物质补充剂,定期到医院随访。     

腹腔镜胃旁路术后病态肥胖症患者微量营养素缺乏的诊治

目的 探讨行腹腔镜胃旁路术后病态肥胖症患者血清微量营养素的变化. 方法回顾性分析121例病态肥胖症患者腹腔镜胃旁路术后6、12、24个月血清铁(Fe)、钙(Ca)、锌(Zn)、硒(Se)及维生素A(VitA)、维生素D(VitD)、维生素B12(VitB12)和甲状旁腺素(PTH)水平的变化.结果 本组121例病态肥胖症患者术前1个月平均体质量指数(body mass index,BMI)为(47±7)kg/m2,术后6个月平均BMI为(34±6)kg/m2,术后BMI平均下降(13±5)kg/m2(P＜0.01).在术后的2年随访中,血清Fe、Ca、Zn、Se、VitA、VitD、VitB12均在正常范围.虽然一些患者的血清Zn、Se和VitA水平偏低,但接近正常.而血清PTH始终高于正常水平,术后6、12、24个月分别升高了(22±34)pg/ml、(28±34)pg/ml、(31±40)pg/ml(P＜0.05).结论 本研究证明腹腔镜胃旁路手术治疗病态肥胖症患者是有效、安全的,但术后患者血清Ca、Zn、Se代谢及PTH水平有所改变.因此,建议所有腹腔镜胃旁路手术患者术后长期服用多种维生素和矿物质补充剂.     

Femoral vein transposition is a durable hemodialysis access for patients who have exhausted upper extremity options

ObjectiveAccess surgeons often encounter patients with end-stage renal disease who have exhausted all upper extremity hemodialysis access options. Although the lower extremity is often the next alternative, prosthetic lower extremity access can be prone to infectious complications and historically has poor patency. We describe our contemporary experience with an autogenous femoral vein transposition (FVT) arteriovenous fistula.MethodsAll FVTs performed at an academic medical center from 2006 to 2018 were analyzed. FVTs were placed after upper extremity access was deemed no longer possible by the treating surgeon. Patient demographics, comorbidities, and access history were described, and perioperative and short-term outcomes, including maturation, were analyzed.ResultsTwenty-one patients treated with FVT were identified. The mean age was 55.3 ± 11.1 years; 23.8% were female, and 71.4% were African American. The median body mass index was 27.1 kg/m² (range, 17-46 kg/m²). Comorbidities included hypertension (100%), diabetes (61.9%), coronary artery disease (57.1%), congestive heart failure (47.6%), and obesity (38.1%). Twenty patients had at least one prior arm access, whereas 13 patients (61.9%) had more than three prior arm accesses. Seventeen patients (81%) had central venous stenosis or occlusion confirmed on preoperative imaging. The mean operative time was 250 minutes (range, 144-406 minutes), and estimated blood loss was 140.5 mL. Preanastomotic tapering was performed in 20 (95.2%) patients. Four (19%) patients returned to the operating room within 30 days. Thirty-day postoperative cardiac and wound complications occurred in 9.5% and 19% of patients, respectively. Distal arterial ischemia requiring revascularization occurred in one (4.8%) patient at 7 months. There were no access-related infections that resulted in fistula ligation. There was no mortality at 30 days. Successful fistula maturation rate at 6 months was 88.9%. At 1 year, primary and secondary patency rates were 65.9%, and 94.7%, respectively.ConclusionsAlthough autogenous FVT performed in patients without upper extremity options has a significant wound complication rate, it is associated with an outstanding maturation rate and excellent patency rates at 1 year. This access should be readily considered in hemodialysis patients without upper extremity access options.     

下肢血管损伤43例诊治分析

目的 探讨下肢血管损伤病变特点、总结诊断与治疗经验。方法 分析复旦大学附属中山医院2002年6月 至 2007年5月诊治的43例血管外伤病人的临床资料,30例为下肢动脉血管损伤,其中男性病人26例。主要为动脉血管损伤,其中髂外动脉损伤5例,股浅动脉损伤10例,股总动脉损伤7例,腘动脉损伤5例,股深动脉损伤2例,胫腓干损伤1例。3例病人因动静脉瘘同时合并静脉损伤。22例病人接受开放手术治疗,6例病人行腔内治疗,2例病人接受药物治疗。结果 开放手术组中2例发生骨筋膜室综合征和缺血再灌注损伤,其中1例因救治无效而死亡,1例经保守治疗后症状缓解;2例腘动脉损伤合并骨折者术后因血管再次栓塞而行截肢术,其余19例术后恢复良好。开放手术组中1例死亡者和2例截肢者失访,其余19例随访2～36个月,1例病人36个月发生人工血管吻合口处中度狭窄,ABI 0.75,其余病人下肢情况良好,无严重并发症发生。腔内治疗组术后症状消失,病人随访6~24个月,支架通畅,无并发症发生。药物组治疗后症状缓解,2例病人随访时间分别为1个月和12个月,间破距离较治疗前延长。结论 下肢血管损伤发病率不高,尽管近年来救治手段有了较大提高,仍有一定的致死率和致残率。腔内治疗是治疗血管外伤的新方法,与传统手术相比有较多优点,短期随访结果满意。     

Increased warm ischemia time during vessel harvest decreases the primary patency of cryopreserved conduits in patients undergoing lower extremity bypass

ObjectiveAutologous vein is the preferred conduit for lower extremity bypass. However, it is often unavailable because of prior harvest or inadequate for bypass owing to insufficient caliber. Cryopreserved cadaveric vessels can be used as conduits for lower extremity revascularization when autogenous vein is not available and the use of prosthetic grafts is not appropriate. Many studies have shown that donor characteristics influence clinical outcomes in solid organ transplantation, but little is known regarding their impact in vascular surgery. The purpose of this study was to examine the effects donor variables have on patients undergoing lower extremity bypass with cryopreserved vessels.MethodsThe tissue processing organization was queried for donor blood type, warm ischemia times (WITs), and serial numbers of cryopreserved vessels implanted at a single center from 2010 to 2016. The serial numbers were then matched with their respective patients using the institutional Clinical Data Repository and patient data were obtained from the Clinical Data Repository and chart review. Primary outcomes were primary patency of the bypass conduits and limb salvage. Time to loss of patency was evaluated using Kaplan-Meier methods and a Cox proportional hazards model determined risk-adjusted predictors of patency and limb salvage.ResultsSixty patients underwent lower extremity bypass with 65 cryopreserved vessels (23 superficial femoral arteries, 41 saphenous veins, 1 femoral vein). Thirty-eight procedures were reoperations. There were 21 inflow, 44 outflow, and 44 infrainguinal procedures. Preexisting comorbidities did not differ significantly between those who lost patency and those who did not. The mean WIT among the entire cohort was 892.3 ± 389.1 minutes (range, 158.0-1434.0 minutes). The median follow-up was 394 days. Kaplan-Meier analysis demonstrated an overall 1-year primary patency rate of 51%. Primary patency at 1 year was 67% and 41% for inflow and outflow procedures, respectively, and did not differ significantly between the two groups (P = .15). Donor-to-recipient ABO incompatibility was not associated with loss of primary patency. The 1-year amputation-free survival was 74%. Primary patency significantly decreased with each hourly increase in WIT on risk-adjusted analysis (hazard ratio, 1.1; P = .02).ConclusionsHigher cryopreserved vessel WIT was associated with increased risk-adjusted loss of primary patency in this cohort. At 1 year, the overall primary patency was 51% and amputation-free survival was 74%. Vascular surgeons should be aware that WIT may affect outcomes for lower extremity bypass.     

利伐沙班预防下肢创伤患者术后静脉血栓栓塞的多中心研究

目的 多中心观察下肢创伤患者术后应用利伐沙班预防静脉血栓栓塞症(VTE)的疗效及安全性.方法 2011年2月至2012年3月全国5家医院共472例下肢创伤(骨盆、髋关节周围、股骨、膝关节和胫腓骨骨折)患者纳入研究,其中男305例(64.6％),女167例(35.4％);年龄18～94岁,平均49.1岁.术后应用利伐沙班抗凝时间至少10d,10 mg,1次/d,口服.分别于术前、手术日、出院日、术后14d和术后30 d进行5次随访,根据双下肢彩色多普勒超声观察VTE的发生情况,同时记录出血事件的发生.结果 所有患者术后口服利伐沙班时间平均为10.9d.随访时根据临床观察及彩色多普勒超声检查发现,9例患者发生VTE(1.9％),均为深静脉血栓形成,未出现肺栓塞.2例患者发生不良事件,均与研究药物无关,未发生出血事件.结论 下肢创伤患者术后应用利伐沙班预防VTE安全、有效.